Bid Publish Date
31-Dec-2024, 11:00 am
Bid End Date
21-Jan-2025, 11:00 am
Location
Progress
Quantity
8380
Nuclear Power Corporation Of India Limited has released a public tender for Item-1, Item-2, Item-3, Item-4, Item-5, Item-6, Item-7, Item-8, Item-9, Item-10 in CHITTORGARH, RAJASTHAN. Quantity: 8380. Submission Deadline: 21-01-2025 11: 00: 00. Download documents and apply online.
Tender Category
Goods
Bid To RA
No
Item Category
Item-1 , Item-2 , Item-3 , Item-4 , Item-5 , Item-6 , Item-7 , Item-8 , Item-9 , Item-10
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
Item-1
SUPPLY OF EYE DROP FLUOROMETHOLONE+TOBRAMYCIN ALL STRENGTH
Item-2
SUPPLY OF EYE DROP TROPICAMIDE+PENYLEPHARINE 0.8%+5%
Item-3
SUPPLY OF INJECTION MEPHENTERMINE 10 ml
Item-4
SUPPLY OF TOPI. SOLUTION HAEMOCOAGULASE 10 ml
Item-5
SUPPLY OF TABLET DROSPIRENONE+ETHINYLESTRADIOL 3+0.03 mg
Item-6
SUPPLY OF INJECTION PROGESTERONE AQUEOUS 25mg/ml
Item-7
SUPPLY OF INJECTION N-BUTANOL+CITRIC ACID 0.26+0.0025
Item-8
SUPPLY OF INJECTION OXYTOCIN 1 ml
Item-9
SUPPLY OF CREAM CONJUGATED ESTROGENS (0.625/gm) 14 g
Item-10
SUPPLY OF EYE DROP CAMPHOR + CARBOXYMETHYL CELLULOSE + NAPAROLINE + PHENYLEPHRINE 0.01+0.5+0.05+0.12 %
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | Item-1 | SUPPLY OF EYE DROP FLUOROMETHOLONE+TOBRAMYCIN ALL STRENGTH | 2,000 | bottle | rrsuser451 | 90 | |
| 2 | Item-2 | SUPPLY OF EYE DROP TROPICAMIDE+PENYLEPHARINE 0.8%+5% | 500 | bottle | rrsuser451 | 90 | |
| 3 | Item-3 | SUPPLY OF INJECTION MEPHENTERMINE 10 ml | 10 | injection | rrsuser451 | 90 | |
| 4 | Item-4 | SUPPLY OF TOPI. SOLUTION HAEMOCOAGULASE 10 ml | 20 | topi solution | rrsuser451 | 90 | |
| 5 | Item-5 | SUPPLY OF TABLET DROSPIRENONE+ETHINYLESTRADIOL 3+0.03 mg | 2,400 | tablet | rrsuser451 | 90 | |
| 6 | Item-6 | SUPPLY OF INJECTION PROGESTERONE AQUEOUS 25mg/ml | 200 | injection | rrsuser451 | 90 | |
| 7 | Item-7 | SUPPLY OF INJECTION N-BUTANOL+CITRIC ACID 0.26+0.0025 | 100 | injection | rrsuser452 | 90 | |
| 8 | Item-8 | SUPPLY OF INJECTION OXYTOCIN 1 ml | 100 | injection | rrsuser451 | 90 | |
| 9 | Item-9 | SUPPLY OF CREAM CONJUGATED ESTROGENS (0.625/gm) 14 g | 50 | tube | rrsuser451 | 90 | |
| 10 | Item-10 | SUPPLY OF EYE DROP CAMPHOR + CARBOXYMETHYL CELLULOSE + NAPAROLINE + PHENYLEPHRINE 0.01+0.5+0.05+0.12 % | 3,000 | bottle | rrsuser451 | 90 |
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | EDISON DRUG HOUSE Under PMA | - | 17-01-2025 20:32:46 | |
| 2 | GARG MEDICAL STORE Under PMA | - | 17-01-2025 15:24:20 | |
| 3 | GULAB MEDICOSE Under PMA | - | 21-01-2025 10:57:14 | |
| 4 | Keps Pharma Under PMA | - | 18-01-2025 17:40:50 | |
| 5 | SUNIL PHARMACY Under PMA | - | 20-01-2025 21:20:45 |
Key insights about RAJASTHAN tender market
The eligibility requirements include being a legally registered entity, compliance with all regulatory requirements for pharmaceutical suppliers, and possessing necessary certifications such as GMP. Additionally, bidders must demonstrate proven experience in supplying medicinal products.
Bidders must provide relevant certificates that showcase compliance with quality standards, including but not limited to GMP certificates, validation certificates, and any other licenses required to operate within the pharmaceutical sector.
To register for this tender, bidders must complete the electronic submission process detailed in the main tender document. This includes entering required company details, uploading necessary documentation, and ensuring compliance with all submission guidelines.
Documents must be submitted in electronic format as specified by the provided bid submission platform. Acceptable formats typically include PDF and Word documents. Ensure all documents are clearly labeled and comply with the submission instructions.
The technical specifications for the medicines include detailed descriptions and quality standards mandated by relevant health authorities. Bidders must provide evidence of compliance with these specifications as part of their submission.
The quality standards refer to certifications and manufacturing practices that ensure the medicines are safe and effective. Documented proof of adherence to national and international standards must accompany each bid.
All bids must comply with the procurement policies as outlined by the Department of Atomic Energy, including compliance with regulatory standards and submission of relevant certificates and documentation.
The testing criteria includes adherence to safety and regulatory standards, potency tests, and stability studies as required by applicable health authorities. Bidders are expected to ensure their products meet these criteria prior to bidding.
The amount for the Earnest Money Deposit (EMD) is specified in the tender documentation. It acts as a security measure to ensure seriousness in the bids submitted. Details regarding the EMD requirements can be found in the main tender document.
Once awarded the contract, successful bidders will be required to submit a performance security. The specifics regarding the amount and conditions for this security are detailed in the tender documentation.
The payment terms for this tender usually stipulate a milestone-based payment system, wherein payments are made upon successful delivery and acceptance of goods according to the requirements specified. Details will be provided in the official tender terms.
Price evaluation will consider the total bid amount, any applicable discounts for bulk orders, and cost competitiveness against other bids submitted. The most favorable pricing along with compliance to specifications will be given preference.
Bids must be submitted electronically via the specified online platform outlined in the tender document. Bidders should ensure compliance with submission guidelines to avoid disqualification.
Key timelines, including submission deadlines and opening dates, are provided in the main tender document. Bidders are encouraged to keep track of these timelines to ensure timely submission.
The evaluation process involves verifying compliance with all eligibility criteria, assessing technical capabilities, and comparing pricing. A committee will review submissions based on these parameters before making a final selection.
The results of the tender evaluation will typically be communicated through the official communication channels provided in the tender documentation. Bidders should check their registered contact information for updates.
MSEs may receive special advantages in the evaluation process, potentially including relaxed eligibility criteria, assistance in documentation, and favorable pricing terms. Specific provisions can be reviewed in the tender details.
Yes, certain provisions for startups include favorable evaluation considerations based on innovative offerings and solutions that meet the needs outlined by the Department of Atomic Energy.
Bidders are encouraged to align their submissions with the 'Make in India' initiative by ensuring a certain level of local content in their medicinal products. Details on local content requirements can be found in the official tender documentation.
Yes, bidders must comply with local content and procurement rules as defined by Indian procurement policy. These guidelines are aimed at promoting domestic manufacturing and quality production. Ensure to verify the specific requirements mentioned in the tender document.
Sign up now to access all documents
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS